Valuation: Clover Corporation Limited

Market Cap 15Cr 11Cr 9.09Cr 8.53Cr 7.79Cr 15Cr 1.01TCr 100.99Cr 39Cr 509.71Cr 40Cr 39Cr 1.69TCr P/E 2026 *
15.2x
P/E 2027 * 11x
Enterprise Value 15Cr 10Cr 8.95Cr 8.4Cr 7.67Cr 14Cr 994.63Cr 99Cr 39Cr 501.78Cr 39Cr 38Cr 1.66TCr EV / Sales 2026 *
1.55x
EV / Sales 2027 * 1.21x
Free-Float
76.93%
Yield 2026 *
-
Yield 2027 * -
1 day-1.93%
1 week-2.20%
Current month-7.29%
1 month-4.81%
3 months+5.95%
6 months+19.46%
Current year+12.66%
1 week 0.87
Extreme 0.87
0.98
1 month 0.87
Extreme 0.87
1
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.525
1.16
3 years 0.34
Extreme 0.337
1.16
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap.
18/11/25 Sell

Chief Executive Officer

2,55,199 0.1528%
18/11/25 Buy

Chief Executive Officer

5,29,638 0.3171%
06/11/25 Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-1.93%-2.20%+53.45%-12.75% 11Cr
0.00%-9.24%+7.65%+65.95% 1.2TCr
-2.10%-0.25%-18.36%+382.72% 917.65Cr
+1.46%-1.62%-22.04%-48.38% 242.5Cr
+2.88%+1.57%-12.78%-3.23% 152.36Cr
-0.04%-0.17%+26.06%+75.28% 136.93Cr
-3.64%-0.08%+34.78%-19.59% 135.41Cr
-0.60%-0.51%-73.16%-73.62% 125.12Cr
-0.27%-2.13%-40.60% - 109.21Cr
-2.97%-7.07%-62.98%-69.27% 97Cr
Average -0.72%+0.78%-10.80%+33.01% 312.85Cr
Weighted average by Cap. -0.65%-2.26%-8.24%+135.74%

Financials

2026 *2027 *
Net sales 9.4Cr 6.74Cr 5.78Cr 5.43Cr 4.96Cr 9.35Cr 642.55Cr 64Cr 25Cr 324.16Cr 25Cr 25Cr 1.07TCr 12Cr 8.32Cr 7.14Cr 6.7Cr 6.12Cr 12Cr 793.62Cr 79Cr 31Cr 400.37Cr 31Cr 31Cr 1.33TCr
Net income 98L 70.24L 60.28L 56.58L 51.68L 97.53L 67Cr 6.7Cr 2.6Cr 34Cr 2.64Cr 2.58Cr 111.94Cr 1.35Cr 96.75L 83.04L 77.94L 71.19L 1.34Cr 92Cr 9.22Cr 3.57Cr 47Cr 3.63Cr 3.55Cr 154.2Cr
Net Debt -23L -16.48L -14.15L -13.28L -12.13L -22.89L -16Cr -1.57Cr -60.9L -7.93Cr -61.89L -60.55L -26Cr -72L -51.6L -44.29L -41.57L -37.97L -71.65L -49Cr -4.92Cr -1.91Cr -25Cr -1.94Cr -1.9Cr -82Cr
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
26/26/26 A$0.8900 -1.93% 56,202
25/26/25 A$0.9075 -0.27% 18,384
24/26/24 A$0.9100 +1.11% 5,064
21/26/21 A$0.9000 -2.70% 20,868
20/26/20 A$0.9250 +1.65% 5,020
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8900AUD
Average target price
1.280AUD
Spread / Average Target
+43.82%

Annual profits - Rate of surprise